Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Offer practical starter options for 2024, including how to evaluate coins, wallets, and purchasing steps for beginners.
23,507 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A newly married couple received a $4,000 invoice from their in-laws after wedding costs exceeded an agreed cap, renew...
As AI workloads push data-center networks to the limit, seven firms are rising as the backbone of AI connectivity. Th...
With stock markets choppy and inflation easing, a growing number of financial planners urge a bridge strategy: withdr...
As AI-driven stocks wobble between skepticism and momentum, HSBC strategists say a turn in valuations could lift pric...
Seagate Technology has rallied about 250% year-to-date as AI storage demand accelerates. This update weighs whether t...
As markets wobble, some Americans are eyeing a Greek island retirement as a cost-conscious path. This piece breaks do...
Relief programs were designed to support small businesses through tough times. This article explains the intent behin...
Investors are weighing SpaceX's first earnings as a public company against a backdrop of limited float and big hype. ...
CoreWeave stock tumbling today underscores the volatility in AI infrastructure plays. This explainer breaks down what...
As April 1 approaches, retirees with traditional IRAs and 401(k)s must act on the first RMD. Missing the initial dist...
A revival in small-cap stocks is taking shape as three key forces converge. AI-driven demand, a steadier macro backdr...